CLASS II ONGOING Device recall · Reported 23 Jul 2025 · FDA Enforcement Report

Eye-sync containing Pico Neo 2 Headsets recalled by NeuroSync

NeuroSync is recalling Eye-sync containing Pico Neo 2 Headsets, distributed nationwide in the US. The recall was initiated on 19 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel No X02. UDI-DI: 00868096000300. Serial Numbers: PA7D50NGF4020311G (Lot P-10114-13), PA7D50NGF4020191G (Lot P-10114-13), PA7D40NGEA080237G (Lot P-10114-12) Software Revisions: Software version uniform across all affected devices
Quantity recalled27 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2114-2025
FDA event ID
97014
Recalling firm
NeuroSync, Holliston, MA
Classification
Class II
Status
Ongoing
Recall initiated
19 Sep 2023
FDA classified
11 Jul 2025
Reported
23 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Packaging Defects
Device type
Medical Software

Timeline

19 Sep 2023Recall initiated by company
11 Jul 2025Classified by FDA+661 days
23 Jul 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Eye syncing issues causing the device to be inoperable. Unable to be repaired due to discontinuation of support for the Pico 2 platform, which was no longer in production or serviceable as of August 31, 2023.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

NeuroSync EYE-SYNC containing Pico Neo 2 Headsets. Each unit consists of a Pico Neo 2 headset with embedded sensors, a paired Android tablet, and proprietary software, packaged in a portable field case. Eye-tracking headset system is intended for recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects. The EYE-SYNC is intended to record, measure, and analyze eye movements as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI).

Where it was distributed

United States Nationwide distribution in the states of New York (NY), Texas (TX), and Georgia (GA).

Nationwide GeorgiaNew YorkTexas

Questions about this recall

Why was it recalled?

Eye syncing issues causing the device to be inoperable. Unable to be repaired due to discontinuation of support for the Pico 2 platform, which was no longer in production or serviceable as of August 31, 2023.

Which lots are affected?

Model No X02. UDI-DI: 00868096000300. Serial Numbers: PA7D50NGF4020311G (Lot P-10114-13), PA7D50NGF4020191G (Lot P-10114-13), PA7D40NGEA080237G (Lot P-10114-12) Software Revisions: Software version uniform across all affected devices

Where was it sold?

United States Nationwide distribution in the states of New York (NY), Texas (TX), and Georgia (GA).

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Medical Software recalls

All 932